A UK patient has died after taking an unapproved drug dubbed the 'Godzilla' of weight-loss jabs - and dozens more have ...

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...

Reata Pharmaceuticals (NASDAQ:RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (NASDAQ:BIIB). That deal has Biogen offering to buy shares of RETA stock for ...

In this article, I’m going to take a look at Reata Pharmaceuticals Inc’s (NASDAQ:RETA) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject ...

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shareholders should be happy to see the share price up 26% in the last month. But that hardly compensates for the shocking decline over the last twelve months ...